Procter&Gamble Standalone September 2020 Net Sales at Rs 263.97 crore, up 17.23% Y-o-Y
Dec 4, 2020 / 09:00 AM IST
Reported Standalone quarterly numbers for Procter & Gamble Health are:Net Sales at Rs 263.97 crore in September 2020 up 17.23% from Rs. 225.17 crore in September 2019.
Quarterly Net Profit at Rs. 59.26 crore in September 2020 up 65.72% from Rs. 35.76 crore in September 2019.
EBITDA stands at Rs. 84.82 crore in September 2020 up 49.78% from Rs. 56.63 crore in September 2019.
Procter&Gamble EPS has increased to Rs. 35.70 in September 2020 from Rs. 21.54 in September 2019.
Procter&Gamble shares closed at 6,745.60 on December 03, 2020 (NSE) and has given 55.70% returns over the last 6 months and 57.27% over the last 12 months.
| Procter & Gamble Health | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'20 | Jun'20 | Sep'19 | | Net Sales/Income from operations | 263.97 | 201.16 | 225.17 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 263.97 | 201.16 | 225.17 | | EXPENDITURE | | Consumption of Raw Materials | 93.05 | 52.77 | 63.82 | | Purchase of Traded Goods | 5.16 | 2.13 | 7.83 | | Increase/Decrease in Stocks | -3.25 | -3.52 | 6.31 | | Power & Fuel | -- | -- | -- | | Employees Cost | 38.69 | 35.57 | 30.27 | | Depreciation | 7.36 | 8.05 | 4.05 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 52.22 | 61.11 | 67.05 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 70.74 | 45.04 | 45.85 | | Other Income | 6.72 | 10.68 | 6.72 | | P/L Before Int., Excpt. Items & Tax | 77.46 | 55.73 | 52.58 | | Interest | 0.24 | -- | -- | | P/L Before Exceptional Items & Tax | 77.22 | 55.73 | 52.58 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 77.22 | 55.73 | 52.58 | | Tax | 17.96 | 6.87 | 16.82 | | P/L After Tax from Ordinary Activities | 59.26 | 48.86 | 35.76 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 59.26 | 48.86 | 35.76 | | Equity Share Capital | 16.60 | 16.60 | 16.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 35.70 | 29.40 | 21.54 | | Diluted EPS | 35.70 | 29.40 | 21.54 | | EPS After Extra Ordinary | | Basic EPS | 35.70 | 29.40 | 21.54 | | Diluted EPS | 35.70 | 29.40 | 21.54 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
_2020091018165303jzv.jpg "Decoding The World Of ETF")
